Oxford Biomedica's manufacturing services offer end-to-end viral vector production with rigorous GMP processes. Their state-of-the-art facilities ensure high-quality, scalable solutions for gene therapy, supporting clinical and commercial needs efficiently.
Vendor
Oxford Biomedica
Company Website
End-to-end viral vector manufacturing services
Proven manufacturing excellence at commercial scale OXB has the technical and regulatory expertise to help you deliver the life-changing medicines of tomorrow. Our commitment to medical innovation, proven experience of scaling up complex manufacturing processes and thorough understanding of product commercialisation give you everything you need to get your product to market.
Benefit from our deep scientific understanding
Working with OXB gives you access to capabilities that go far beyond conventional contract manufacturing services for viral vectors. Our commercial experience, scientific understanding, and development expertise complement our state of the art manufacturing facilities. Our teams are passionate about helping you get the results you want.
Benefit from our rigorous controls
When you use an OXB platform, you get a comprehensive, end-to-end CMC service. You can be sure our quality-focused GMP manufacturing processes will support your viral vector product through every step of development through to commercialisation, all supported by robust and compliant analytics.